STOCKHOLM, November 4, 2020 - In accordance with the resolution passed by Elekta's (EKTA-B.ST) Annual General Meeting on
The Nomination Committee consists of:
·
· Per Colleen, appointed by the
· Filippa Gerstädt, appointed by Nordea Funds
· Javiera Ragnartz, appointed by SEB Funds
· Tomas Risbecker, appointed by AMF and AMF Funds
The Nomination Committee will appoint one of its members as Chairman.
The Nomination Committee is to present proposals for resolutions by the 2021 Annual General Meeting of Shareholders in relation to the following: Chairman of the Annual General Meeting of Shareholders; Chairman of the Board of Directors and other members of the Board of Directors; fees to the Board of Directors; external auditor and fees to the auditor; and where deemed necessary, proposal to amend the procedure for the Nomination Committee.
Shareholders wishing to submit proposals to Elekta's Nomination Committee can do so by e-mail to valberedningen@elekta.com or by letter to:
Att: Nomination Committee
Box 7593
SE-103 93 Stockholm
In order for the Nomination Committee to be able to process any proposals constructively, these should be received by the Committee no later than
# # #
For further information, please contact:
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in
https://news.cision.com/elekta/r/elekta-s-nomination-committee-for-the-2021-annual-general-meeting,c3230621
https://mb.cision.com/Main/35/3230621/1329978.pdf
(c) 2020 Cision. All rights reserved., source